Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Novartis

Food Allergy Treatment Market Is Set to Triple — What it...

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for...

Parents Who Have Lost a Child to Anaphylaxis Speak Out in...

Symjepi, the Once Promising Emergency Epinephrine Device, Continues to Stumble

Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...

FDA Confirms Adrenaclick® Generic and EpiPen® Still in Short Supply with...

Protecting Against Severe Allergic Reactions This Summer

Symjepi, the Auto-Injector Alternative, to Launch Q1 2019

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Symjepi Back on Track After Adamis Finds Commercialization Partner

Follow Us

Your School On Our Map

Put Your School on the Map